A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

The goal of this clinical trial is to learn if tattoos applied with Magic Ink is as safe as commercially available standard tattoo ink for the purpose of radiation in women with breast cancer undergoing radiation treatment. The main questions are: * Is the Magic Ink as safe as standard tattoo ink * Does Magic Ink continue to function and remain visible for radiation therapists during the treatment Participants will be consented and given a skin assessment. Once enrolled participants will be administered the Magic Ink tattoo instead of the standard tattoo ink in preparation for their radiation

Trial Details

NCT ID
NCT07095114
Phase
NA
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
RECRUITING
Cancer Type
Lobular Carcinoma Breast Cancer
Interventions
  • Magic Ink
Locations (sample)
  • Detroit, Michigan, United States|42.33143,-83.04575

Key Eligibility Criteria

  • Participant must have histologically or cytologically confirmed stage 0 ductal carcinoma in situ (DCIS), I, II or III breast cancer and be planning…
  • Participants must be 18 years of age or older
  • Participant must be able to understand a written informed consent document and be willing to sign it
  • Participant must be assigned female at birth

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lobular Carcinoma Breast Cancer Trials on Trialify →